SPFPL THIBAUD MEUNIER PHARMACIEN : revenue, balance sheet and financial ratios

SPFPL THIBAUD MEUNIER PHARMACIEN is a French company founded 17 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in LYON (69009), this company of category PME shows in 2022 a revenue of 258 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL THIBAUD MEUNIER PHARMACIEN (SIREN 507990935)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C 257 713 € N/C N/C N/C N/C 930 610 € 930 337 €
Net income 48 100 € -2 958 € -17 927 € -97 642 € 53 349 € 83 978 € 62 342 € 76 946 € 72 197 € 48 355 €
EBITDA -3 604 € -4 759 € -6 968 € 29 051 € N/C N/C N/C N/C 111 084 € 73 290 €
Net margin N/C N/C N/C -37.9% N/C N/C N/C N/C 7.8% 5.2%

Revenue and income statement

In 2025, SPFPL THIBAUD MEUNIER PHARMACIEN generates positive net income of 48 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 48 k€ -> 48 k€.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-3 604 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-3 605 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

48 100 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 65%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 10.3 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

65.158%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

60.142%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

10.293

Solvency indicators evolution
SPFPL THIBAUD MEUNIER PHARMACIEN

Sector positioning

Debt ratio
65.16 2025
2023
2024
2025
Q1: 0.0
Med: 4.29
Q3: 41.73
Average

In 2025, the debt ratio of SPFPL THIBAUD MEUNIER PHA... (65.16) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
60.14% 2025
2023
2024
2025
Q1: 8.5%
Med: 48.09%
Q3: 82.21%
Good

In 2025, the financial autonomy of SPFPL THIBAUD MEUNIER PHA... (60.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
10.29 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.0 years
Q3: 1.55 years
Watch +50 pts over 3 years

In 2025, the repayment capacity of SPFPL THIBAUD MEUNIER PHA... (10.29) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 596.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

596.001

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-171.337

Liquidity indicators evolution
SPFPL THIBAUD MEUNIER PHARMACIEN

Sector positioning

Liquidity ratio
596.0 2025
2023
2024
2025
Q1: 148.71
Med: 349.75
Q3: 1213.74
Good +6 pts over 3 years

In 2025, the liquidity ratio of SPFPL THIBAUD MEUNIER PHA... (596.00) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-171.34x 2025
2023
2024
2025
Q1: -0.32x
Med: 0.0x
Q3: 0.63x
Average

In 2025, the interest coverage of SPFPL THIBAUD MEUNIER PHA... (-171.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 150 days. Excellent situation: suppliers finance 150 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

150 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL THIBAUD MEUNIER PHARMACIEN

Positioning of SPFPL THIBAUD MEUNIER PHARMACIEN in its sector

Comparison with sector Conseil pour les affaires et autres conseils de gestion

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (35 transactions). This range of 150 842€ to 540 630€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2025
Indicative
150k€ 265k€ 540k€
265 558 € Range: 150 842€ - 540 630€
NAF 5 année 2025

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 35 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Conseil pour les affaires et autres conseils de gestion)

Compare SPFPL THIBAUD MEUNIER PHARMACIEN with other companies in the same sector:

Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion

Frequently asked questions about SPFPL THIBAUD MEUNIER PHARMACIEN

What is the revenue of SPFPL THIBAUD MEUNIER PHARMACIEN ?

The revenue of SPFPL THIBAUD MEUNIER PHARMACIEN in 2022 is 258 k€.

Is SPFPL THIBAUD MEUNIER PHARMACIEN profitable?

Yes, SPFPL THIBAUD MEUNIER PHARMACIEN generated a net profit of 48 k€ in 2025.

Where is the headquarters of SPFPL THIBAUD MEUNIER PHARMACIEN ?

The headquarters of SPFPL THIBAUD MEUNIER PHARMACIEN is located in LYON (69009), in the department Rhone.

Where to find the tax return of SPFPL THIBAUD MEUNIER PHARMACIEN ?

The tax return of SPFPL THIBAUD MEUNIER PHARMACIEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL THIBAUD MEUNIER PHARMACIEN operate?

SPFPL THIBAUD MEUNIER PHARMACIEN operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.